Alejandro Gonzalez-Candia

Dr. Alejandro Gonzalez-Candia

Universidad de O'higgins (UOH)
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2015 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
FTFlavio Torres
Flavio Torres
AGAlejandro Gonzalez-Candia
Alejandro Gonzalez-Candia
CMCamilo Montt
Camilo Montt
GEGermán Ebensperger
Germán Ebensperger
MCMagdalena Chubretovic
Magdalena Chubretovic
EHEmilio A. Herrera
Emilio A. Herrera

11 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
RCRodrigo Castillo
Rodrigo Castillo
EHEmilio A. Herrera
Emilio A. Herrera
AGAlejandro Gonzalez-Candia
Alejandro Gonzalez-Candia
MRMarjorie Reyes-Farias
Marjorie Reyes-Farias
NJNicole De La Jara
Nicole De La Jara
Catalina Carrasco-PozoCatalina Carrasco-Pozo
Catalina Carrasco-Pozo
Alterations in cardiac energy metabolism play a key role in the pathogenesis of diabetic cardiomyopathy. Hypercholesterolemia associated with bioenergetic impairment and oxidative stress has not been well characterized in the cardiac function under glycemic control deficiency conditions. This work aimed to determine the cardioprotective effects of quercetin (QUE) against the damage induced by a high‐cholesterol (HC) diet in hyperglycemic rats, addressing intracellular antioxidant mechanisms and bioenergetics. Quercetin reduced HC‐induced alterations in the lipid profile and glycemia in rats. In addition, QUE attenuated cardiac diastolic dysfunction (increased E:A ratio), prevented cardiac cholesterol accumulation, and reduced the increase in HC‐induced myocyte density. Moreover, QUE reduced HC‐induced oxidative stress by preventing the decrease in GSH/GSSG ratio, Nrf2 nuclear translocation, HO‐1 expression, and antioxidant enzymatic activity. Quercetin also counteracted HC‐induced bioenergetic impairment, preventing a reduction in ATP levels and alterations in PGC‐1α, UCP2, and PPARγ expression. In conclusion, the mechanisms that support the cardioprotective effect of QUE in rats with HC might be mediated by the upregulation of antioxidant mechanisms and improved bioenergetics on the heart. Targeting bioenergetics with QUE can be used as a pharmacological approach to modulate structural and functional changes of the heart under hypercholesterolemic and hyperglycemic conditions.

1 April 2019 in Redox Biology
Verified
Journal Article
Open access
AGAlejandro Gonzalez-Candia
Alejandro Gonzalez-Candia
MVMarcelino Veliz
Marcelino Veliz
Catalina Carrasco-PozoCatalina Carrasco-Pozo
Catalina Carrasco-Pozo
RCRodrigo L. Castillo
Rodrigo L. Castillo
JCJ. Cesar Cárdenas
J. Cesar Cárdenas
EHEmilio A. Herrera
Emilio A. Herrera
Chronic hypobaric hypoxia during fetal and neonatal life induces neonatal pulmonary hypertension. Hypoxia and oxidative stress are driving this condition, which implies an increase generation of reactive oxygen species (ROS) and/or decreased antioxidant capacity. Melatonin has antioxidant properties that decrease oxidative stress and improves pulmonary vascular function when administered postnatally. However, the effects of an antenatal treatment with melatonin in the neonatal pulmonary function and oxidative status are unknown. Therefore, we hypothesized that an antenatal therapy with melatonin improves the pulmonary arterial pressure and antioxidant status in high altitude pulmonary hypertensive neonates. Twelve ewes were bred at high altitude (3600 m); 6 of them were used as a control group (vehicle 1.4% ethanol) and 6 as a melatonin treated group (10 mg d-1 melatonin in vehicle). Treatments were given once daily during the last third of gestation (100-150 days). Lambs were born and raised with their mothers until 12 days old, and neonatal pulmonary arterial pressure and resistance, plasma antioxidant capacity and the lung oxidative status were determined. Furthermore, we measured the pulmonary expression and activity for the antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase, and the oxidative stress markers 8-isoprostanes, 4HNE and nitrotyrosine. Finally, we assessed pulmonary pro-oxidant sources by the expression and function of NADPH oxidase, mitochondria and xanthine oxidase. Melatonin decreased the birth weight. However, melatonin enhanced the plasma antioxidant capacity and decreased the pulmonary antioxidant activity, associated with a diminished oxidative stress during postnatal life. Interestingly, melatonin also decreased ROS generation at the main pro-oxidant sources. Our findings suggest that antenatal administration of melatonin programs an enhanced antioxidant/pro-oxidant status, modulating ROS sources in the postnatal lung.

1 August 2016 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
AGAlejandro Gonzalez-Candia
Alejandro Gonzalez-Candia
MVMarcelino Veliz
Marcelino Veliz
CAClaudio Araya
Claudio Araya
SQSebastian Quezada
Sebastian Quezada
GEGermán Ebensperger
Germán Ebensperger
EHEmilio A. Herrera
Emilio A. Herrera

6 March 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
CACristian R. Astorga
Cristian R. Astorga
AGAlejandro Gonzalez-Candia
Alejandro Gonzalez-Candia
ACAlejandro A. Candia
Alejandro A. Candia
Esteban FigueroaEsteban Figueroa
Esteban Figueroa
DCDaniel Cañas
Daniel Cañas
EHEmilio A. Herrera
Emilio A. Herrera
Background: Chronic hypoxia and oxidative stress during gestation lead to pulmonary hypertension of the neonate (PHN), a condition characterized by abnormal pulmonary arterial reactivity and remodelling. Melatonin has strong antioxidant properties and improves pulmonary vascular function. Here, we aimed to study the effects of melatonin on the function and structure of pulmonary arteries from PHN lambs. Methods: Twelve lambs (Ovis aries) gestated and born at highlands (3,600 m) were instrumented with systemic and pulmonary catheters. Six of them were assigned to the control group (CN, oral vehicle) and 6 were treated with melatonin (MN, 1 mg.kg-1.d-1) during 10 days. At the end of treatment, we performed a graded oxygenation protocol to assess cardiopulmonary responses to inspired oxygen variations. Further, we obtained lung and pulmonary trunk samples for histology, molecular biology and immunohistochemistry determinations. Results: Melatonin reduced the in vivo pulmonary pressor response to oxygenation changes. In addition, melatonin decreased cellular density of the media and diminished the proliferation marker KI67 in resistance vessels and pulmonary trunk (p<0.05). This was associated with a decreased in the remodelling markers α-actin (CN 1.28±0.18 vs. MN 0.77±0.04, p<0.05) and smoothelin-B (CN 2.13±0.31 vs. MN 0.88±0.27, p<0.05). Further, melatonin increased vascular density by 134% and vascular luminal surface by 173% (p<0.05). Finally, melatonin decreased nitrotyrosine, an oxidative stress marker, in small pulmonary vessels (CN 5.12±0.84 vs. MN 1.14±0.34, p<0.05). Conclusion: Postnatal administration of melatonin blunts the cardiopulmonary response to hypoxia, reduces the pathological vascular remodelling, and increases angiogenesis in pulmonary hypertensive neonatal lambs. These effects improve the pulmonary vascular structure and function in the neonatal period under chronic hypoxia.

Verified
Journal Article
Open access
PDF file
MAMiguel Aguilar
Miguel Aguilar
AGAlejandro Gonzalez-Candia
Alejandro Gonzalez-Candia
JRJorge Rodríguez
Jorge Rodríguez
Catalina Carrasco-PozoCatalina Carrasco-Pozo
Catalina Carrasco-Pozo
DCDaniel Cañas
Daniel Cañas
RCRodrigo Castillo
Rodrigo Castillo
More than 140 million people live and works (in a chronic or intermittent form) above 2500 m worldwide and 35 million live in the Andean Mountains. Furthermore, in Chile, it is estimated that 55,000 persons work in high altitude shifts, where stays at lowlands and interspersed with working stays at highlands. Acute exposure to high altitude has been shown to induce oxidative stress in healthy human lowlanders, due to an increase in free radical formation and a decrease in antioxidant capacity. However, in animal models, intermittent hypoxia (IH) induce preconditioning, like responses and cardioprotection. Here, we aimed to describe in a rat model the responses on cardiac and vascular function to 4 cycles of intermittent hypobaric hypoxia (IHH). Twelve adult Wistar rats were randomly divided into two equal groups, a four-cycle of IHH, and a normobaric hypoxic control. Intermittent hypoxia was induced in a hypobaric chamber in four continuous cycles (1 cycle = 4 days hypoxia + 4 days normoxia), reaching a barometric pressure equivalent to 4600 m of altitude (428 Torr). At the end of the first and fourth cycle, cardiac structural, and functional variables were determined by echocardiography. Thereafter, ex vivo vascular function and biomechanical properties were determined in femoral arteries by wire myography. We further measured cardiac oxidative stress biomarkers (4-Hydroxy-nonenal, HNE; nytrotirosine, NT), reactive oxygen species (ROS) sources (NADPH and mitochondrial), and antioxidant enzymes activity (catalase, CAT; glutathione peroxidase, GPx, and superoxide dismutase, SOD). Our results show a higher ejection and shortening fraction of the left ventricle function by the end of the 4th cycle. Further, femoral vessels showed an improvement of vasodilator capacity and diminished stiffening. Cardiac tissue presented a higher expression of antioxidant enzymes and mitochondrial ROS formation in IHH, as compared with normobaric hypoxic controls. IHH exposure determines a preconditioning effect on the heart and femoral artery, both at structural and functional levels, associated with the induction of antioxidant defence mechanisms. However, mitochondrial ROS generation was increased in cardiac tissue. These findings suggest that initial states of IHH are beneficial for cardiovascular function and protection.